These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3774866)

  • 1. [Improvement of the dissolution behavior of problem drugs. 11. DTA iomeglamic-PVP 25 copreciptates].
    Fahr F; Kala H; Masthoff F; Fries G
    Pharmazie; 1986 Jul; 41(7):517. PubMed ID: 3774866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improvement of the dissolution behavior of problem drugs. 4. Differential thermal analysis of iomeglamic acid-succinic acid embedding].
    Fahr F; Kala H; Masthoff F
    Pharmazie; 1985 Apr; 40(4):270-1. PubMed ID: 4011664
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improvement of the dissolution behavior of problem drugs. 3. X-ray diffraction measurement of iomeglamic acid/succinic acid solid dispersions].
    Fahr F; Kala H; Pollandt P
    Pharmazie; 1985 Feb; 40(2):127-8. PubMed ID: 4001148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement of the solubility behavior of problem drugs. 20. The effect of pharmaceutical excipients on the wetability of iomeglamic acid].
    Fahr F; Zessin G; Kala H; Fries G
    Pharmazie; 1989 Aug; 44(8):576-7. PubMed ID: 2594830
    [No Abstract]   [Full Text] [Related]  

  • 5. [The improvement of solubility behavior of problem drugs. 2. Solubility behavior of slow dissolving products of iomeglamic acid and succinic acid].
    Fahr F; Kala H; Scharrenweber F
    Pharmazie; 1985 Jan; 40(1):60-1. PubMed ID: 3991791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvement of the solubility behavior of problem drugs. 9. In vitro absorption studies using melting solidification products of iomeglamic acid].
    Fahr F; Neubert R; Fürst W; Kala H; Masthoff F
    Pharmazie; 1986 Dec; 41(12):855-6. PubMed ID: 3575388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets].
    Fahr F; Kala H; Hückel T; Fries G
    Pharmazie; 1988 Mar; 43(3):216. PubMed ID: 3380870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder].
    Fahr F; Kala H; Fries G; Helbig G
    Pharmazie; 1988 Mar; 43(3):217. PubMed ID: 3380871
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improvement of the solubility of problem drugs. 15. X-ray diffraction of iomeglamic acid-methylcellulose (MH 300)-PEG 6000-coprecipitate].
    Fahr F; Kala H; Pollandt P; Hückel T; Fries G
    Pharmazie; 1987 Aug; 42(8):554. PubMed ID: 3432342
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement of the solubility of problem drugs. 1. Production of iomeglamic acid fused and solidified products].
    Fahr F; Kala H; Pollandt P; Wenzel U; Masthoff F
    Pharmazie; 1985 Jun; 40(6):408-9. PubMed ID: 4034650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The improvement of solubility behavior of problem drugs. 7. Iomeglamic acid-mannitol-melting viscosity products].
    Fahr F; Kala H; Pollandt P; Zessin G
    Pharmazie; 1985 Oct; 40(10):733-4. PubMed ID: 3936061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Improvement of the solubility of problem drugs. 15. Alteration of iomeglamic acid-methylcellulose (MH 300)-PEG 6000 coprecipitates].
    Fahr F; Kala H; Pollandt P; Fries G; Hückel T
    Pharmazie; 1987 Aug; 42(8):552-3. PubMed ID: 3432340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of iomeglamic acid (Falignost)].
    Pfeifer S; Schäffner J; Bornschein I
    Pharmazie; 1972 Jun; 27(6):396-403. PubMed ID: 5082266
    [No Abstract]   [Full Text] [Related]  

  • 15. Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.
    Rahamathulla M; Hv G; Rathod N
    Pak J Pharm Sci; 2008 Oct; 21(4):350-5. PubMed ID: 18930854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Granulometric determination of the effect of polyvinylpyrrolidone on the dissolution rates of difficultyly soluble drugs (author's transl)].
    Voigt R; Terborg D
    Pharmazie; 1980; 34(5-6):311-2. PubMed ID: 7413707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems.
    Esnaashari S; Javadzadeh Y; Batchelor HK; Conway BR
    Int J Pharm; 2005 Mar; 292(1-2):227-30. PubMed ID: 15725569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of selected derivatives of 1,4-benzodiazepine-2-one in the presence of PVP.
    Cwiertnia B
    Acta Pol Pharm; 2008; 65(4):487-91. PubMed ID: 19051592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interactions between macromolecular excipients and drugs. 5. Association between polyvinylpyrrolidone and phenothiazine derivatives].
    Voigt R; Schultze HH; Keipert S
    Pharmazie; 1976; 31(12):863-9. PubMed ID: 15287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.